In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds

Chemotherapy

Volumn 48, Issue 2, 2002, Pages 78-81

  Nakai, Toru ^a,b   Uno, J ^a   Otomo, K ^b   Ikeda, F ^b   Tawara, S ^b   Goto, T ^b   Nishimura, K ^a   Miyaji, M ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Antifungal activity; Dermatiaceous fungi; FK463; Microdilution; Molds

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN;

ABSIDIA; ARTICLE; ASCOMYCETES; ASPERGILLUS; CLADOSPORIUM; CUNNINGHAMELLA; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; EXOPHIALA; FONSECAEA PEDROSOI; FUNGUS ISOLATION; FUSARIUM SOLANI; IN VITRO STUDY; MOULD; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS ORYZAE;

ASPERGILLUS; FUNGI; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC;

EID: 0036249138     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057666     Document Type: Article

References (18)

1. Fungal infections: A growing threat
2. Disseminated infection with Fusarium in recipients of bone marrow transplants
3. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
4. Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodifor-misstrain in a renal transplant patient
5. Chromoblastomycosis caused by Exophiala spinifera
6. The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection
7. Infections due to dematiaceous fungi in organ transplant recipients: Case report and review
8. Resistance of Candida species to fluconazole
9. Suggested mechanisms for the antimycotic activity of the polyene antibiotics and N-substituted imidazoles
10. Wf11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties
11. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
12. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
13. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
14. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
15. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis
16. The cell wall of fungal human pathogens: Its possible role in host-parasite relationships
17. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts